Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.7 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.12 | 0.7 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |